Effectiveness of Behavioral Activation Treatment for Schizophrenia
Study Details
Study Description
Brief Summary
The purpose of this study is to implement a behavior activation remote program for negative symptoms of schizophrenia and to verify whether the behavior activation remote program for negative symptoms of schizophrenia has effects on negative symptoms, cognitive function, and social function of schizophrenia.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Behavioral activation Behavioral activation |
Behavioral: behavioral activation
Behavioral Activation (BA) is a specific CBT skill. It can be a treatment all by itself, or can be used alongside other CBT skills such as cognitive restructuring.
Behavioral activation helps us understand how behaviors influence emotions, just like cognitive work helps us understand the connection between thoughts and emotions.
|
Placebo Comparator: Traatment as usual
|
Behavioral: behavioral activation
Behavioral Activation (BA) is a specific CBT skill. It can be a treatment all by itself, or can be used alongside other CBT skills such as cognitive restructuring.
Behavioral activation helps us understand how behaviors influence emotions, just like cognitive work helps us understand the connection between thoughts and emotions.
|
Outcome Measures
Primary Outcome Measures
- negative function [three month]
improved negative function
Secondary Outcome Measures
- cognitive function [three month]
improved cognitive function
- depressed mood [three month]
improved depressed mood
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients who have received a primary diagnosis of schizophrenia
-
Patients who are at least 18 years old and under 65 years old
-
Patients who show a score of 3 or higher on at least two negative symptom items in the Positive and Negative Syndrome Scale (PANSS)
-
The subject selection period is until December 31, 2021, from the IRB approval date.
Exclusion Criteria:
-
Patients with a history of organic brain syndrome, epilepsy, or traumatic brain injury
-
Patients with comorbidities such as intellectual disability, current alcohol or other substance dependence
-
Patients who show a score of 5 or higher on at least two positive symptom items in the Positive and Negative Syndrome Scale (PANSS)
-
Patients who have received a diagnosis of major depressive disorder according to the DSM-V criteria by a specialist in psychiatry
-
Patients who have received psychological services including components of behavioral activation therapy
-
Patients who are at risk of self-harm or harm to others.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Inha university hospital | Incheon | Jung-Gu | Korea, Republic of | 22332 |
Sponsors and Collaborators
- Inha University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2021-01-026